sj-docx-1-mpp-10.1177_23814683221137752 – Supplemental material for Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

sj-docx-5-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-5-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-1-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-10-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-10-opp-10.1177_10781552221126102 for Transition to ePrescribing for s...

sj-docx-1-hpq-10.1177_13591053231216017 – Supplemental material for A qualitative feasibility and acceptability study of an acceptance and commitment-based bibliotherapy intervention for people with cancer

Emma Keenan (4673317)
Reg Morris (17713529)
Vasilis S Vasiliou (17713532)
Andrew R Thompson (5498237)

December 2023

Supplemental material, sj-docx-1-hpq-10.1177_13591053231216017 for A qualitative feasibility and acc...

sj-docx-1-tam-10.1177_17588359221128356 – Supplemental material for Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations

Chenfei Chi (6039347)
Jiazhou Liu (10643840)
Liancheng Fan (5641550)
Yinjie Zhu (736022)
Yanqing Wang (250075)
Jianjun Sha (550443)
Yiran Huang (1450759)
Baijun Dong (329955)
Jiahua Pan (550442)
Wei Xue (219900)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221128356 for Efficacy of neoadjuvant docetaxel...

sj-docx-1-mdm-10.1177_0272989X231156430 – Supplemental material for Increasing Inclusivity and Reducing Reactance During Provider-Patient Interactions

Lillianna Shields (14676814)
Tony Stovall (14676817)
Helen Colby (14676820)

February 2023

Supplemental material, sj-docx-1-mdm-10.1177_0272989X231156430 for Increasing Inclusivity and Reduci...

sj-docx-1-tam-10.1177_17588359231220501 – Supplemental material for Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+ advanced breast cancer patients

Yuehua Liang (14016078)
Xiaoran Liu (1553812)
Zehui Yun (17531507)
Kun Li (277035)
Huiping Li (617425)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220501 for Endocrine therapy plus HER2-targe...

AJMH835326_Supplemental_material__CLN – Supplemental material for Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems

Jun Tang (32983)
Lixian Zhong (320758)
Carly Paoli (6428333)
Alan Paciorek (3799345)
Peter Carroll (6428336)
Leslie Wilson (32629)

March 2019

Supplemental material, AJMH835326_Supplemental_material__CLN for Longitudinal Comparison of Patient-...

sj-docx-1-opp-10.1177_10781552231210788 - Supplemental material for Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies

Nadia A Nabulsi (13029586)
Lisa K Sharp (17372588)
Karen I Sweiss (17372591)
Pritesh R Patel (17372594)
Gregory S Calip (13029601)
Todd A Lee (7943360)

November 2023

Supplemental material, sj-docx-1-opp-10.1177_10781552231210788 for Patterns of prescription opioid u...

sj-docx-1-mdm-10.1177_0272989X221126678 – Supplemental material for Multicriteria Decision-Making Methods for Optimal Treatment Selection in Network Meta-Analysis

Ioannis Bellos (5432687)

September 2022

Supplemental material, sj-docx-1-mdm-10.1177_0272989X221126678 for Multicriteria Decision-Making Met...

Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection

R. A. Gafanov
A. G. Dzidzaria
I. B. Kravtsov
S. V. Fastovets

January 2019

The treatment landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has rapidly evolved...

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

D. Andrew Loblaw
David S. Mendelson
James A. Talcott
Katherine S. Virgo
Mark R. Somerfield
Edgar Ben-josef
Richard Middleton
Henry Porterfield
Stewart A. Sharp
Thomas J. Smith
Mary Ellen Taplin
Nicholas J. Vogelzang
James L. Wade
Charles L. Bennett
Howard I. Scher

January 2004

To develop a clinical practice guideline for the management of men with metastatic, recurrent, or pr...

sj-docx-1-uro-10.1177_20514158221145775 – Supplemental material for Prostate cancer among South Asian men in the United Kingdom: A systematic review

Zoe Panayi (14420891)
Shalom J Srirangam (14420894)

January 2023

Supplemental material, sj-docx-1-uro-10.1177_20514158221145775 for Prostate cancer among South Asian...

sj-docx-1-tam-10.1177_17588359231220506 – Supplemental material for Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study

Jian Pan (419768)
Tingwei Zhang (5992331)
Shouzhen Chen (739104)
Ting Bu (14360241)
Jinou Zhao (12839957)
Xudong Ni (9440018)
Benkang Shi (739112)
Hualei Gan (5506016)
Yu Wei (365236)
Qifeng Wang (123379)
Beihe Wang (6513929)
Junlong Wu (6093629)
Shaoli Song (412493)
Feng Wang (44414)
Chang Liu (35901)
Dingwei Ye (691205)
Yao Zhu (441601)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence ...

sj-docx-2-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-2-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-5-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-5-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-1-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-10-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-10-opp-10.1177_10781552221126102 for Transition to ePrescribing for s...

sj-docx-1-hpq-10.1177_13591053231216017 – Supplemental material for A qualitative feasibility and acceptability study of an acceptance and commitment-based bibliotherapy intervention for people with cancer

Emma Keenan (4673317)
Reg Morris (17713529)
Vasilis S Vasiliou (17713532)
Andrew R Thompson (5498237)

December 2023

Supplemental material, sj-docx-1-hpq-10.1177_13591053231216017 for A qualitative feasibility and acc...

sj-docx-1-tam-10.1177_17588359221128356 – Supplemental material for Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations

Chenfei Chi (6039347)
Jiazhou Liu (10643840)
Liancheng Fan (5641550)
Yinjie Zhu (736022)
Yanqing Wang (250075)
Jianjun Sha (550443)
Yiran Huang (1450759)
Baijun Dong (329955)
Jiahua Pan (550442)
Wei Xue (219900)

September 2022

Supplemental material, sj-docx-1-tam-10.1177_17588359221128356 for Efficacy of neoadjuvant docetaxel...

sj-docx-1-mdm-10.1177_0272989X231156430 – Supplemental material for Increasing Inclusivity and Reducing Reactance During Provider-Patient Interactions

Lillianna Shields (14676814)
Tony Stovall (14676817)
Helen Colby (14676820)

February 2023

Supplemental material, sj-docx-1-mdm-10.1177_0272989X231156430 for Increasing Inclusivity and Reduci...

sj-docx-1-tam-10.1177_17588359231220501 – Supplemental material for Endocrine therapy plus HER2-targeted therapy, another favorable option for HR+/HER2+ advanced breast cancer patients

Yuehua Liang (14016078)
Xiaoran Liu (1553812)
Zehui Yun (17531507)
Kun Li (277035)
Huiping Li (617425)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220501 for Endocrine therapy plus HER2-targe...

AJMH835326_Supplemental_material__CLN – Supplemental material for Longitudinal Comparison of Patient-Level Outcomes and Costs Across Prostate Cancer Treatments With Urinary Problems

Jun Tang (32983)
Lixian Zhong (320758)
Carly Paoli (6428333)
Alan Paciorek (3799345)
Peter Carroll (6428336)
Leslie Wilson (32629)

March 2019

Supplemental material, AJMH835326_Supplemental_material__CLN for Longitudinal Comparison of Patient-...

sj-docx-1-opp-10.1177_10781552231210788 - Supplemental material for Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies

Nadia A Nabulsi (13029586)
Lisa K Sharp (17372588)
Karen I Sweiss (17372591)
Pritesh R Patel (17372594)
Gregory S Calip (13029601)
Todd A Lee (7943360)

November 2023

Supplemental material, sj-docx-1-opp-10.1177_10781552231210788 for Patterns of prescription opioid u...

sj-docx-1-mdm-10.1177_0272989X221126678 – Supplemental material for Multicriteria Decision-Making Methods for Optimal Treatment Selection in Network Meta-Analysis

Ioannis Bellos (5432687)

September 2022

Supplemental material, sj-docx-1-mdm-10.1177_0272989X221126678 for Multicriteria Decision-Making Met...

Metastatic hormone-sensitive prostate cancer: Practical guidelines and optimization of therapy selection

R. A. Gafanov
A. G. Dzidzaria
I. B. Kravtsov
S. V. Fastovets

January 2019

The treatment landscape for metastatic hormone-sensitive prostate cancer (mHSPC) has rapidly evolved...

American Society of Clinical Oncology recommendations for the initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer

D. Andrew Loblaw
David S. Mendelson
James A. Talcott
Katherine S. Virgo
Mark R. Somerfield
Edgar Ben-josef
Richard Middleton
Henry Porterfield
Stewart A. Sharp
Thomas J. Smith
Mary Ellen Taplin
Nicholas J. Vogelzang
James L. Wade
Charles L. Bennett
Howard I. Scher

January 2004

To develop a clinical practice guideline for the management of men with metastatic, recurrent, or pr...

sj-docx-1-uro-10.1177_20514158221145775 – Supplemental material for Prostate cancer among South Asian men in the United Kingdom: A systematic review

Zoe Panayi (14420891)
Shalom J Srirangam (14420894)

January 2023

Supplemental material, sj-docx-1-uro-10.1177_20514158221145775 for Prostate cancer among South Asian...

sj-docx-1-tam-10.1177_17588359231220506 – Supplemental material for Nomogram to predict the presence of PSMA-negative but FDG-positive lesion in castration-resistant prostate cancer: a multicenter cohort study

Jian Pan (419768)
Tingwei Zhang (5992331)
Shouzhen Chen (739104)
Ting Bu (14360241)
Jinou Zhao (12839957)
Xudong Ni (9440018)
Benkang Shi (739112)
Hualei Gan (5506016)
Yu Wei (365236)
Qifeng Wang (123379)
Beihe Wang (6513929)
Junlong Wu (6093629)
Shaoli Song (412493)
Feng Wang (44414)
Chang Liu (35901)
Dingwei Ye (691205)
Yao Zhu (441601)

January 2024

Supplemental material, sj-docx-1-tam-10.1177_17588359231220506 for Nomogram to predict the presence ...

sj-docx-2-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-2-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-5-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-5-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-1-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-1-opp-10.1177_10781552221126102 for Transition to ePrescribing for sy...

sj-docx-10-opp-10.1177_10781552221126102 - Supplemental material for Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital

Hannah O’Connor (14069036)
Gail Melanophy (11000016)
Carlos Medina Martin (14069039)
Martin Flattery (14069042)
Edel O’Dea (14069045)

November 2022

Supplemental material, sj-docx-10-opp-10.1177_10781552221126102 for Transition to ePrescribing for s...

sj-docx-1-mpp-10.1177_23814683221137752 – Supplemental material for Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

Abstract

Extracted data

sj-docx-1-mpp-10.1177_23814683221137752 – Supplemental material for Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer

Abstract

Extracted data

Topics

Related items

Topics

Related items